Magellan sells TREK business to Thermo Fisher

Magellan Biosciences, a global manufacturer of products designed to make diagnostic testing easier, more cost-effective, and less labor intensive, announced that it has sold its microbiology business, TREK Diagnostic Systems, to Thermo Fisher Scientific (NYSE: TMO). The sale will enable Magellan to focus all its resources on its LeadCare® and Dynex® businesses, both of which have been experiencing strong growth. Terms of the sale were not disclosed.

"Thermo Fisher is an ideal home for the TREK business and its 150 employees around the world," commented Magellan's President and CEO, Hiroshi Uchida, Ph.D. "TREK's automated blood culture, microbial identification, and microbial susceptibility testing platforms complement Thermo Fisher's portfolio of microbiology technologies. We will now focus on realizing our ambitious plans for expanding the reach and growth of our remaining businesses," Dr. Uchida continued. "This is an exciting time for Magellan."

Source:

Magellan Biosciences

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thermo Fisher Scientific Inc.. (2019, June 19). Magellan sells TREK business to Thermo Fisher. News-Medical. Retrieved on August 05, 2021 from https://www.news-medical.net/news/20110719/Magellan-sells-TREK-business-to-Thermo-Fisher.aspx.

  • MLA

    Thermo Fisher Scientific Inc.. "Magellan sells TREK business to Thermo Fisher". News-Medical. 05 August 2021. <https://www.news-medical.net/news/20110719/Magellan-sells-TREK-business-to-Thermo-Fisher.aspx>.

  • Chicago

    Thermo Fisher Scientific Inc.. "Magellan sells TREK business to Thermo Fisher". News-Medical. https://www.news-medical.net/news/20110719/Magellan-sells-TREK-business-to-Thermo-Fisher.aspx. (accessed August 05, 2021).

  • Harvard

    Thermo Fisher Scientific Inc.. 2019. Magellan sells TREK business to Thermo Fisher. News-Medical, viewed 05 August 2021, https://www.news-medical.net/news/20110719/Magellan-sells-TREK-business-to-Thermo-Fisher.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Thermo Scientific MAS Omni Infectious Controls launched to assess the performance of serological assays